Caffeine might ease anxiety and depression by calming brain inflammation

Caffeine appears to alleviate symptoms of anxiety and depression in rodents by reducing inflammation in the brain. A recent systematic review of 17 animal studies found that the widely consumed stimulant consistently diminished behavioral signs of distress and lowered levels of inflammatory molecules. The findings were published in Translational Psychiatry.

Mental health conditions like anxiety and depression involve physical changes in the nervous system. Over the past few decades, researchers have identified neuroinflammation as a major contributor to these mood disorders. When the body experiences chronic psychological stress or illness, the immune system often responds by releasing proteins called cytokines.

These cytokines travel to the brain and activate specialized immune cells known as microglia and astrocytes. Once activated, these glial cells can disrupt the normal balance of neurotransmitters like dopamine and serotonin. This inflammatory process can trigger behaviors associated with mood disorders, such as a loss of motivation or heightened fear responses.

Caffeine is a psychoactive substance that primarily works by blocking adenosine receptors in the brain. Adenosine is a chemical that naturally accumulates during the day, binding to specific receptors to promote sleepiness. By blocking these receptors, caffeine keeps the brain alert.

Adenosine receptors are not just involved in wakefulness. A specific subtype, called the A2A receptor, is prominently featured on the surface of microglia and astrocytes. Prolonged stress can cause an overabundance of these A2A receptors, which makes the brain’s immune cells highly sensitive and prone to causing inflammation.

Free daily newsletter

Because caffeine blocks these A2A receptors, scientists suspect it might act as a brake on the brain’s inflammatory response. Neurobiologists Laís da Silva Neves and Paula Campello-Costa at the Fluminense Federal University in Brazil wanted to synthesize the existing data on this topic. Along with their colleagues, they set out to analyze how caffeine influences both brain inflammation and behavior in animal models.

The research team conducted a systematic review, a process that involves collecting and evaluating all the published scientific literature on a specific research question. They combed through online databases and identified 17 rodent studies that met their strict inclusion criteria. Every selected study featured a control group to allow for objective comparisons.

The team first looked at six studies focusing on anxiety. In these experiments, researchers induced anxiety in adult rats through various stressful scenarios. These included acute stressors, like a brief period of sleep deprivation or exposure to the scent of a predator, as well as chronic stressors, such as repeated physical restraint.

During or after these stressful events, the rodents received caffeine. The method of administration varied by study. Some animals received the substance through their drinking water, while others were given direct injections or fed through a gastric tube.

Scientists then measured the animals’ anxiety levels using established behavioral tests. A common method involves placing the rodent in an elevated, cross-shaped maze with both open and enclosed arms. Anxious animals will generally hide in the dark, enclosed arms, while less anxious animals will spend more time exploring the exposed sections.

Neves, Campello-Costa, and their team noted that caffeine consistently promoted exploratory behaviors, indicating a reduction in anxiety. This behavioral shift was accompanied by distinct physical changes in the animals’ brains. The rodents treated with caffeine exhibited lower levels of oxidative stress, a type of cellular damage associated with psychological strain.

Brain tissue analysis also revealed a drop in several pro-inflammatory cytokines, including interleukin-6 and tumor necrosis factor-alpha. At the same time, the caffeine-treated animals showed increased levels of anti-inflammatory molecules. The substance effectively prevented the microglia and astrocytes from entering a highly reactive, damaging state.

The remaining eleven studies in the review focused on animal models of depression. To mimic the biological mechanisms of depression, researchers in several of these studies injected the mice or rats with lipopolysaccharide. This molecule is a structural component of bacterial cell walls, and injecting it tricks the animal’s immune system into launching a massive, body-wide inflammatory response.

Other depression models utilized chronic unpredictable mild stress or long-term sleep deprivation. To assess whether the animals had entered a depressive-like state, researchers used tests that measure motivation and the capacity to experience pleasure. For example, they tracked whether the rodents lost interest in drinking sweetened water, a behavior that mirrors the loss of pleasure seen in human depression.

Across the different models, caffeine administration protected the rodents from developing these depressive-like behaviors. The animals maintained their motivation in physical tests and continued to seek out rewards like sugar water. In some of the studies, caffeine performed just as well as standard antidepressant medications like imipramine.

When examining the biological data from these depression models, the reviewers found a similar pattern to the anxiety studies. Caffeine reversed the chemical changes induced by the bacterial components or the chronic stress. The treated rodents displayed higher levels of protective antioxidant enzymes and fewer inflammatory markers in regions of the brain associated with memory and emotion.

A few of the evaluated studies also tested substances closely related to caffeine, such as caffeic acid and green tea extract. These compounds provided similar mood-boosting and anti-inflammatory benefits. Some research even suggested that standard caffeinated coffee and decaffeinated coffee both lowered inflammation, though the behavioral benefits were sometimes tied strictly to the caffeine.

While the review points to a robust anti-inflammatory effect, translating these findings to humans requires caution. Animal models can replicate specific neurochemical mechanisms, but they cannot capture the subjective, conscious experience of human anxiety or depression. The behavioral tests only act as proxies for actual mood disorders.

Almost all the studies in this review used adult male rodents. This uniformity makes the data easier to pool and compare, but it leaves a major gap in the scientific literature. It remains unknown if caffeine produces the exact same neuroinflammatory responses in female rodents or in animals at different developmental stages, such as adolescents or the elderly.

The amount of caffeine administered in these experiments also varied widely. Some doses were relatively low, mimicking the concentration a human might get from a standard cup of coffee. Other studies used extremely high doses that would be toxic to humans.

One study in the review actually demonstrated that a massive dose of caffeine worsened anxiety and increased brain inflammation in sleep-deprived rats. High doses of stimulants are known to trigger panic and hyperactivity in both humans and animals. Future research will need to determine the exact doses and consumption habits required to safely harness caffeine’s anti-inflammatory properties for mental health treatments.

The study, “Effects of caffeine on neuroinflammation in anxiety and depression: a systematic review of rodent studies,” was authored by Laís da Silva Neves, Giovanna Várzea Roberti Monteiro de Mattos, Yasmin Oliveira-Nazareth, Rosane Souza da Silva, and Paula Campello-Costa.